THE PRESENCE OF β‐ADRENERGIC RECEPTORS IN THE HEPATIC VASCULATURE

Aida Geumei, Mohamed Mahfouz

British Journal of Pharmacology and Chemotherapy · 1968 · 18 citations · 14 references

DOIFull text

Open access

Concepts

Abstract

The liver is ideally equipped to play a prominent part in systemic adjustments in both physiological and pathological conditions.By accommodating one-quarter of the total cardiac output per minute (Bender & Horvath, 1963, 1965), and by holding 25-30% of the total blood volume, the liver is the principal determinant of the venous return to the heart (Coleridge & Hemingway, 1958; Knisely, Harding & Debacker, 1957).The innervation of the liver vasculature seems to be exclusively derived from the sympathetic nervous system.The first proof for the existence of a vasomotor mechanism within the liver was that of Frangois-Frank & Hallion in 1896.They found that stimula- tion of the sympathetic supply caused a rise of hepatic and portal pressures and shrinkage of the liver.No other drug or group of drugs has been so extensively investigated in the hepatic circulation as the catecholamines and related drugs.Studies have been performed on isolated preparations as well as in intact animals and man with differing results.In the isolated perfused liver, both adrenaline and noradrenaline cause reduction in flow (Bauer, Dale, Poulson & Richards, 1932; Chakravarti & Tripod, 1940; Daniel & Prichard, 1951; Andrews, Hecker, Maegraith & Ritchie, 1955; Andrews Hecker & Maegraith, 1956).This response is blocked by ergotoxine (Bauer et al., 1932), azapetine, and phenoxybenzamine (Green, Hall, Sexton & Deal, 1959).In intact animals and in man, however, adrenaline can apparently lead to an increase of hepatic blood flow, possibly secondary to a rise in blood pressure

References

14